Renaissance Technologies’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-626,789
| Closed | -$74M | – | 3917 |
|
|
2020
Q4 | $74M | Sell |
626,789
-216,238
| -26% | -$25.1M | 0.08% | 252 |
|
|
2020
Q3 | $93.7M | Buy |
843,027
+219,886
| +35% | +$23.6M | 0.09% | 227 |
|
|
2020
Q2 | $63.7M | Buy |
623,141
+371,745
| +148% | +$39.8M | 0.06% | 363 |
|
|
2020
Q1 | $27.1M | Buy |
251,396
+205,696
| +450% | +$23.6M | 0.03% | 628 |
|
|
2019
Q4 | $5.32M | Buy |
45,700
+30,700
| +205% | +$3.56M | ﹤0.01% | 1813 |
|
|
2019
Q3 | $1.72M | Buy |
15,000
+5,900
| +65% | +$587K | ﹤0.01% | 2356 |
|
|
2019
Q2 | $867K | Sell |
9,100
-21,900
| -71% | -$2.06M | ﹤0.01% | 2748 |
|
|
2019
Q1 | $2.83M | Buy |
31,000
+22,900
| +283% | +$1.87M | ﹤0.01% | 2134 |
|
|
2018
Q4 | $615K | Sell |
8,100
-46,700
| -85% | -$3.44M | ﹤0.01% | 2787 |
|
|
2018
Q3 | $4.38M | Sell |
54,800
-68,800
| -56% | -$6.41M | ﹤0.01% | 1891 |
|
|
2018
Q2 | $12.3M | Buy |
123,600
+11,900
| +11% | +$1.03M | 0.01% | 1230 |
|
|
2018
Q1 | $9.05M | Buy |
111,700
+9,400
| +9% | +$760K | 0.01% | 1433 |
|
|
2017
Q4 | $8.06M | Sell |
102,300
-99,800
| -49% | -$8.3M | 0.01% | 1510 |
|
|
2017
Q3 | $18.6M | Buy |
202,100
+120,000
| +146% | +$11.5M | 0.02% | 944 |
|
|
2017
Q2 | $9.29M | Sell |
82,100
-166,900
| -67% | -$18.7M | 0.01% | 1320 |
|
|
2017
Q1 | $24.9M | Buy |
249,000
+102,504
| +70% | +$11M | 0.03% | 676 |
|
|
2016
Q4 | $15.8M | Sell |
146,496
-115,604
| -44% | -$13.5M | 0.02% | 935 |
|
|
2016
Q3 | $32.6M | Buy |
262,100
+33,100
| +14% | +$3.91M | 0.06% | 444 |
|
|
2016
Q2 | $24.3M | Sell |
229,000
-140,700
| -38% | -$16.3M | 0.05% | 572 |
|
|
2016
Q1 | $42.3M | Sell |
369,700
-7,400
| -2% | -$868K | 0.08% | 295 |
|
|
2015
Q4 | $53.7M | Sell |
377,100
-12,000
| -3% | -$1.39M | 0.12% | 196 |
|
|
2015
Q3 | $34.9M | Buy |
389,100
+69,600
| +22% | +$7.35M | 0.08% | 290 |
|
|
2015
Q2 | $36.8M | Sell |
319,500
-29,222
| -8% | -$3.07M | 0.08% | 274 |
|
|
2015
Q1 | $33.3M | Buy |
348,722
+72,622
| +26% | +$5.43M | 0.07% | 365 |
|
|
2014
Q4 | $18.6M | Buy |
276,100
+53,500
| +24% | +$3.32M | 0.04% | 549 |
|
|
2014
Q3 | $12M | Buy |
222,600
+22,500
| +11% | +$1.11M | 0.03% | 659 |
|
|
2014
Q2 | $8.9M | Buy |
200,100
+69,725
| +53% | +$2.85M | 0.02% | 909 |
|
|
2014
Q1 | $4.53M | Buy |
130,375
+11,975
| +10% | +$381K | 0.01% | 1316 |
|
|
2013
Q4 | $3.42M | Buy |
118,400
+23,900
| +25% | +$693K | 0.01% | 1430 |
|
|
2013
Q3 | $2.76M | Buy |
94,500
+9,700
| +11% | +$242K | 0.01% | 1507 |
|
|
2013
Q2 | $1.97M | Buy |
+84,800
| New | +$2.14M | 0.01% | 1590 |
|
Other funds holding CBPO
AC
Renaissance Technologies's CBPO Position: Q1 2021 in Review
Renaissance Technologies sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 626,789 shares — an estimated $74M sold.
Renaissance Technologies first reported a position in CBPO in Q2 2013 and held it in 31 quarters. The position peaked at $93.7M in Q3 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.
- Renaissance Technologies reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
- Renaissance Technologies sold 626,789 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $74M.
- Renaissance Technologies first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 31 quarters.
- Renaissance Technologies's China Biologic Products Holdings, Inc. position peaked at $93.7M in Q3 2020.
- 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.